|
Apr 5
|
Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today
|
|
Apr 3
|
Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024
|
|
Apr 1
|
Eupraxia Pharmaceuticals Reports Fourth Quarter and 2023 Financial Results
|
|
Jan 8
|
Eupraxia Pharmaceuticals Announces Filing of Preliminary MJDS Base Shelf Prospectus
|
|
Nov 14
|
Eupraxia Pharmaceuticals Reports Third Quarter 2023 Financial Results
|
|
Aug 11
|
Eupraxia Pharmaceuticals Reports Second Quarter 2023 Financial Results
|
|
May 25
|
Eupraxia Pharmaceuticals Announces Last Patient Last Visit in Phase 2 Osteoarthritis Clinical Trial of EP-104IAR
|